Income tax expense · 2011–2025
Supernus Pharmaceuticals income tax expense
−$10.5M−$34.5M · FY2025
Supernus Pharmaceuticals (SUPN) reported −$10.5M in income tax expense for fiscal 2025, −$34.5M from the year before.
| Fiscal year | Income tax expense | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | −$10.5M | −$34.5M | Open → |
| FY20242024-12-31 | $24.0M | +1,552.1% | Open → |
| FY20232023-12-31 | $1.5M | +4,440.6% | Open → |
| FY20222022-12-31 | $32,000 | −99.8% | Open → |
| FY20212021-12-31 | $19.8M | −52.6% | Open → |
| FY20202020-12-31 | $41.7M | +21.1% | Open → |
| FY20192019-12-31 | $34.4M | +18.0% | Open → |
| FY20182018-12-31 | $29.2M | −32.7% | Open → |
| FY20172017-12-31 | $43.3M | +$84.2M | Open → |
| FY20162016-12-31 | −$40.9M | −$41.5M | Open → |
| FY20152015-12-31 | $666,000 | +5.7% | Open → |
| FY20142014-12-31 | $630,000 | +$630,000 | Open → |
| FY20132013-12-31 | $0 | $0 | Open → |
| FY20122012-12-31 | $0 | +$16.2M | Open → |
| FY20112011-12-31 | −$16.2M | — | Open → |
Income tax expense — Income tax expense is the tax a company charged against profit in its income statement for the year. It is not the same as the cash it handed to tax authorities: deferred tax, provisions and timing differences separate the two, often by billions. The cash figure is a different line in the cash-flow statement.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026
Income tax expense at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Supernus Pharmaceuticals income tax expense |url=https://companiesranked.com/en/company/supernus-pharmaceuticals/income-tax-expense |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Supernus Pharmaceuticals income tax expense. CompaniesRanked. https://companiesranked.com/en/company/supernus-pharmaceuticals/income-tax-expenseBibTeX
@misc{companiesranked-en-company-supernus-pharmaceuticals-income-tax-expense-2026,
author = {{CompaniesRanked}},
title = {{Supernus Pharmaceuticals income tax expense}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/supernus-pharmaceuticals/income-tax-expense}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-K · 0001356576-26-000011 · March 2, 2026
{{cite web |title=Supernus Pharmaceuticals income tax expense — 10-K (0001356576-26-000011) |url=https://www.sec.gov/Archives/edgar/data/1356576/000135657626000011/supn-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-03-02}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.